HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis.

AuthorsBenjamin Ungar, Leore Lavin, Alexandra K Golant, Alyssa Gontzes, Eden David, Yeriel D Estrada, Giselle K Singer, Ana B Pavel, Emma Guttman-Yassky
JournalAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology (Ann Allergy Asthma Immunol) Vol. 128 Issue 6 Pg. 734-736 (06 2022) ISSN: 1534-4436 [Electronic] United States
PMID35346880 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Viral
  • dupilumab
Topics
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Viral
  • Antibody Formation
  • Dermatitis, Atopic (drug therapy)
  • Humans
  • SARS-CoV-2
  • Severity of Illness Index
  • Treatment Outcome
  • COVID-19 Drug Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: